# NOA-12: BIBF1120 and R-RT in Glioblastoma

> **NCT01666600** · PHASE1,PHASE2 · TERMINATED · sponsor: **Prof. Dr. Wolfgang Wick** · enrollment: 63 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** BIBF 1120
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT01666600
- **Lead sponsor:** Prof. Dr. Wolfgang Wick
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2017-03
- **Final completion:** 2017-09
- **Target enrollment:** 63 (ACTUAL)
- **Why stopped:** Interim Analysis for Feasibility
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666600, "NOA-12: BIBF1120 and R-RT in Glioblastoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01666600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*